Table 2 Resuscitation and operative strategies, multi-organ failure, and mortality with respect to periods
Before the negotiation period (n = 65) | During the negotiation period (n = 29) | p | |
|---|---|---|---|
PRBCs * | 2 (0–4) | 2 (0–3) | 0.27 |
Crystalloids * | 5050 (3350–7650) | 4400 (3350–6400) | 0.35 |
Required activation of the TTP | 28 | 10 | 0.49 |
Required surgery, n | 61 | 26 | 0.67 |
DCL, n | 14 | 7 | 0.79 |
Ostomies, n | 10 | 1 | 0.16 |
Amputations, n | 13 | 5 | 1 |
SOFA score * | 3 (1–7) | 3 (1–7) | 0.97 |
Organ dysfunction | |||
Renal dysfunction, n | 9 | 9 | 0.08 |
Hemodynamic dysfunction, n | 14 | 8 | 0.6 |
Coagulopathy, n | 41 | 20 | 0.8 |
Respiratory dysfunction, n | 48 | 17 | 0.13 |
Organ failure | |||
Cardiovascular failure, n | 13 | 8 | 0.5 |
Coagulation failure, n | 6 | 2 | 1 |
Respiratory failure, n | 16 | 7 | 1 |
Mortality, n | 1 | 0 | 0.9 |